Identification of TMB, CD8 T‐cell abundance, and homologous repair pathway mutation frequency as predictors of the benefit–toxicity ratio of anti‐PD‐1/PD‐L1 therapy

Detalles Bibliográficos
Autores principales: Long, Junyu, Yang, Xu, Bian, Jin, Wang, Dongxu, Wang, Anqiang, Lin, Yu, Zheng, Mingjun, Zhang, Haohai, Sang, Xinting, Zhao, Haitao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Letter to Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8597891/
https://www.ncbi.nlm.nih.gov/pubmed/34841682
http://dx.doi.org/10.1002/ctm2.598

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8597891/
https://www.ncbi.nlm.nih.gov/pubmed/34841682
http://dx.doi.org/10.1002/ctm2.598

Ejemplares similares